
Jan Christop L. Merene
Examiner (ID: 18719, Phone: (571)270-5032 , Office: P/3733 )
| Most Active Art Unit | 3733 |
| Art Unit(s) | 3733, 3773 |
| Total Applications | 1047 |
| Issued Applications | 660 |
| Pending Applications | 88 |
| Abandoned Applications | 313 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9435021
[patent_doc_number] => 20140112928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'ANTIBODIES AGAINST TROPOMYOSIN-RELATED KINASE B RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 14/116186
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6763
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116186
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116186 | Antibodies against tropomyosin-related kinase B receptors | May 17, 2012 | Issued |
Array
(
[id] => 8853552
[patent_doc_number] => 20130143227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'REGULATION OF WNT/BETA-CATENIN SIGNALING'
[patent_app_type] => utility
[patent_app_number] => 13/475657
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8425
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475657
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475657 | Regulation of Wnt/beta-catenin signaling | May 17, 2012 | Issued |
Array
(
[id] => 9463262
[patent_doc_number] => 20140127689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'CXCR1 AS A PREDICTOR OF RESPONSE TO TREATMENT WITH EPIDERMAL GROWTH FACTOR RECEPTOR THERAPEUTIC'
[patent_app_type] => utility
[patent_app_number] => 14/113783
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9629
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113783
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113783 | CXCR1 as a predictor of response to treatment with epidermal growth factor receptor therapeutic | Apr 24, 2012 | Issued |
Array
(
[id] => 8347822
[patent_doc_number] => 20120208745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'TREATMENT OF HIV'
[patent_app_type] => utility
[patent_app_number] => 13/450597
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4615
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450597
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/450597 | TREATMENT OF HIV | Apr 18, 2012 | Abandoned |
Array
(
[id] => 8441428
[patent_doc_number] => 20120258045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'INHIBITORS AND METHODS OF TREATMENT OF CARDIOVASCULAR DISEASES, AND METHODS FOR IDENTIFYING INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/448223
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12572
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448223
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/448223 | INHIBITORS AND METHODS OF TREATMENT OF CARDIOVASCULAR DISEASES, AND METHODS FOR IDENTIFYING INHIBITORS | Apr 15, 2012 | Abandoned |
Array
(
[id] => 10932068
[patent_doc_number] => 20140335090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'THERAPEUTIC AGENT FOR CANCER, AND METHOD FOR DETERMINING PROGNOSIS OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/009026
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3423
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009026
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/009026 | THERAPEUTIC AGENT FOR CANCER, AND METHOD FOR DETERMINING PROGNOSIS OF CANCER | Mar 29, 2012 | Abandoned |
Array
(
[id] => 9756251
[patent_doc_number] => 20140286952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'Inhibitors of Metastasis, Methods of Generating Such Inhibitors and Their Therapeutic Applications'
[patent_app_type] => utility
[patent_app_number] => 14/007683
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 22816
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007683
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/007683 | Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications | Mar 29, 2012 | Issued |
Array
(
[id] => 9517745
[patent_doc_number] => 20140154238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'Compositions And Methods For Treating, Diagnosing And Monitoring Disease'
[patent_app_type] => utility
[patent_app_number] => 14/007932
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9360
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007932
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/007932 | Compositions and methods for treating, diagnosing and monitoring disease | Mar 27, 2012 | Issued |
Array
(
[id] => 9656265
[patent_doc_number] => 20140227270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'BISPECIFIC ANTI-CXCR7 IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS'
[patent_app_type] => utility
[patent_app_number] => 14/008011
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 54306
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008011
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008011 | BISPECIFIC ANTI-CXCR7 IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | Mar 27, 2012 | Abandoned |
Array
(
[id] => 9656265
[patent_doc_number] => 20140227270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'BISPECIFIC ANTI-CXCR7 IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS'
[patent_app_type] => utility
[patent_app_number] => 14/008011
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 54306
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008011
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008011 | BISPECIFIC ANTI-CXCR7 IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | Mar 27, 2012 | Abandoned |
Array
(
[id] => 8417577
[patent_doc_number] => 20120245077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'PROKINETICIN 1 RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 13/429773
[patent_app_country] => US
[patent_app_date] => 2012-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 33427
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13429773
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/429773 | PROKINETICIN 1 RECEPTOR | Mar 25, 2012 | Abandoned |
Array
(
[id] => 9293994
[patent_doc_number] => 20140037628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/110189
[patent_app_country] => US
[patent_app_date] => 2012-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17001
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110189
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110189 | Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer | Mar 20, 2012 | Issued |
Array
(
[id] => 9211579
[patent_doc_number] => 20140010756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/006048
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14632
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006048
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/006048 | COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER | Mar 15, 2012 | Abandoned |
Array
(
[id] => 9211579
[patent_doc_number] => 20140010756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/006048
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14632
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006048
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/006048 | COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER | Mar 15, 2012 | Abandoned |
Array
(
[id] => 8489469
[patent_doc_number] => 20120288876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'NOVEL IDENTIFIED ONCOGENE WITH KINASE-DOMAIN (NOK)'
[patent_app_type] => utility
[patent_app_number] => 13/419096
[patent_app_country] => US
[patent_app_date] => 2012-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12289
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13419096
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/419096 | NOVEL IDENTIFIED ONCOGENE WITH KINASE-DOMAIN (NOK) | Mar 12, 2012 | Abandoned |
Array
(
[id] => 9295262
[patent_doc_number] => 20140038897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'TFEB VARIANTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/003505
[patent_app_country] => US
[patent_app_date] => 2012-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12193
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003505
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/003505 | TFEB variants and uses thereof | Mar 6, 2012 | Issued |
Array
(
[id] => 9572180
[patent_doc_number] => 20140189893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'METHOD OF IDENTIFYING COMPOUNDS THAT SPECIFICALLY MODULATE THE INTERACTION OF FGFR1 AND BETA KLOTHO'
[patent_app_type] => utility
[patent_app_number] => 14/116406
[patent_app_country] => US
[patent_app_date] => 2012-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12128
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116406
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116406 | METHOD OF IDENTIFYING COMPOUNDS THAT SPECIFICALLY MODULATE THE INTERACTION OF FGFR1 AND BETA KLOTHO | Feb 19, 2012 | Abandoned |
Array
(
[id] => 8710314
[patent_doc_number] => 20130067603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'SPERM-SPECIFIC CATION CHANNEL, CATSPER4, AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/371033
[patent_app_country] => US
[patent_app_date] => 2012-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20065
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13371033
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/371033 | Sperm-specific cation channel, CatSper4, and uses therefor | Feb 9, 2012 | Issued |
Array
(
[id] => 11283739
[patent_doc_number] => 09499584
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'GPCR with improved cell surface expression'
[patent_app_type] => utility
[patent_app_number] => 14/375316
[patent_app_country] => US
[patent_app_date] => 2012-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8897
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375316
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/375316 | GPCR with improved cell surface expression | Jan 30, 2012 | Issued |
Array
(
[id] => 10375716
[patent_doc_number] => 20150260724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'CELL BASED SENSOR'
[patent_app_type] => utility
[patent_app_number] => 14/375334
[patent_app_country] => US
[patent_app_date] => 2012-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10592
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375334
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/375334 | Cell based sensor | Jan 30, 2012 | Issued |